| What is RSS feed? | About Us |
 |
 Search Score: 4/10
Source: www.ncbi.nlm.nih.gov --- 20 days ago
Basic science and Clinical Research advances in the pituitary transcription factors: Pit-1 and Prop-1. Curr Opin Endocrinol Diabetes Obes. 2008 Aug;15(4):359-63 Authors: Kerr J, Wood W, Ridgway EC PURPOSE OF REVIEW: The pituitary-specific transcription factors, Pit-1 (also called Pou1f1) and prophet of Pit-1 (Prop-1), are critical for normal pituitary development and function. The aim of the present review is to highlight the recent basic science and Clinical Research advances in these transcription factors, as they relate to signaling pathway interactions, gene regulation, and mutations in human diseases. RECENT FINDINGS: A number of important basic Research discoveries have been made in the area of the pituitary-specific transcription factors, Pit-1 and Prop-1. Among these findings include: the effects of the Pit-1 coactivators, GATA-2 and TRAP-220, on the transcriptional regulation of the TSHbeta gene and thyrotropin expression, characterization of a novel pituitary regulator of Pit-1 expression, Atbf1, elucidation of the roles of Wnt and Notch signaling on Prop-1-mediated specification of the Pit-1 cell lineage and gonadotropes, and the identification of regulatory regions of the Prop-1 gene. Advances in Clinical Research include: the identification of novel mutations in the human POU1F1 and PROP-1 genes, and screening guidelines for patients with combined pituitary hormone deficiencies and possible mutations in these transcription ... Source: finance.sympatico.msn.ca --- 19 days ago
... Source: www.law.harvard.edu --- 21 days ago
Would you like to do Research work for the prosecution in Counterterrorism and related national security cases? ... Source: www.prweb.com --- 4 days ago
July 26 Exclusive Seminar, teaching the Ancient Secret that defines the difference between a cancer survivor and a person who succumbs to cancer, using Ras-Con (the key) to mastering this principal available for anyone wise enough to learn it. (PRWeb Jul 19, 2008) Read the full story at http://www.prweb.com/releases/business-success-seminar/medical-spa/prweb1123904.htm ... Source: www.businesswire.com --- 6 days ago
HASBROUCK HEIGHTS, N.J.--(BUSINESS WIRE)--Nymox Pharmaceutical Corporation’s (NASDAQ: NYMX) NicAlert™ product has gained acceptance ... Source: upcoming.yahoo.com --- 6 days ago
Attending this conference will enable you to grasp a global perspective of conducting Clinical Research and the regulatory, cultural and logistical challenges to overcome. You will obtain in depth knowledge of conducting Clinical trials on the international arena. ... Source: www.medicalnewstoday.com --- 2 days ago
Introgen Therapeutics, Inc. (NASDAQ:INGN), a developer of targeted molecular therapies for cancer, announced that the company will present the results from its recently completed Phase 3 trial of ADVEXIN in recurrent head and neck cancer at the American Association for Cancer Research (AACR) Centennial Conference on Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine. The conference will be held July 20-23, 2008 at the Hyatt Regency Monterey in Monterey, CA. ... Source: extension.ucsd.edu --- 21 days ago
As an introduction to both the field of Clinical trials and the certificate programs, this course provides a basic introduction and overview of the Clinical Research process and the two Clinical Trials certificates. Participants receive information on how to best complete the program and conduct a job search in this area based on their background and experience. ... Source: upcoming.yahoo.com --- 4 days ago
Attending this conference will enable you to grasp a global perspective of conducting Clinical Research and the regulatory, cultural and logistical challenges to overcome. ... Source: www.drugs.com --- 7 days ago
BERKELEY HEIGHTS, N.J.--(BUSINESS WIRE)--Jul 14, 2008 - Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC, NASDAQ:CYCCP) announced the publication of a study conducted by Cyclacel scientists showing synergistic activity between its investigational therapy... ... Source: chronicle.com --- 2 days ago
Uniformed Services University of the Health Sciences (Maryland) ... Source: www.eurekalert.org --- 20 days ago
( American Society of Hematology ) Twenty hematology and hematology/oncology fellows and junior faculty will begin a unique year-long education and mentoring program this summer as part of the American Society of Hematology Clinical Research Training Institute. ... Source: chronicle.com --- 8 days ago
The National Institutes of Health has reduced several multimillion-dollar awards it was expected to give each of 14 academic institutions this year to invigorate Clinical Research, leaving the universities to fill in the gaps. ... Source: www.jobs.ac.uk --- 6 days ago
Institute of for Science and Technology in Medicine / Faculty of Health - Keele University / Date of entry: 17/07/08 ... Source: www.educationpages.net --- 6 days ago
... Source: kcnsp.jobseu.recruitadvantage.com --- 17 days ago
... Source: www.educationpages.net --- 17 days ago
... Source: www.pharmatimes.com --- 8 days ago
A new Clinical Research Centre that will serve as a hub for Clinical studies and Research projects in areas such as cancer, heart disease, diabetes and mental illness has officially opened at Ninewells Hospital in Dundee, Scotland ... Source: www.insideindianabusiness.com --- 14 days ago
West Lafayette-based Bioanalytical Systems, Inc. (Nasdaq: BASI) has sold its Baltimore Clinical Pharmacology Research Unit for $850,000 to a subsidiary of Algorithme Pharma Holdings, Inc. The Montreal-based Research organization provides human Clinical trials for Phase I and bioequivalence studies, as well as bioanalytical services, to pharmaceutical and biotechnology companies worldwide. As a result of the sale, BASi will exit the Phase I first-in-human Clinical study market. ... Source: www.newswise.com --- 19 days ago
Robert S. Klein, MD a HIV/AIDS expert has joined the faculty at Mount Sinai School of Medicine as Professor of Medicine and member of the Epidemiology, Biostatistics and Disease Prevention Institute. Dr. Klein will be Director of Clinical Research of Infectious Disease in the Division of Infectious Disease at Mount Sinai. He will develop his own Research program while mentoring junior Clinical investigators within the Division of Infectious Disease. ... Find more results for Clinical Research on RSSMicro.com |
Copyright © 2008 RSSMicro.com
